当前位置: 首页 > 期刊 > 《中国医学创新》 > 2016年第15期
编号:12858336
帕金森病冻结步态患者血清尿酸水平变化及意义(4)
http://www.100md.com 2016年5月25日 《中国医学创新》 2016年第15期
     [14] Squadrito G L,Cueto R,Splenser A E,et al.Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid[J].Arch Biochem Biophys,2000,376(2):333-337.

    [15] De Vera M,Rahman M M,Rankin J,et al.Gout and the risk of Parkinson’s disease: a cohort study[J].Arthritis Rheum,2008,59(11):1549-1554.

    [16] O’Reilly E J,Gao X,Weisskopf M G,et al.Plasma urate and Parkinson’s disease in women[J].Am J Epidemiol,2010,172(6):666-670.

    [17] Schiess M,Oh I.Serum uric acid and clinical progression in Parkinson’s disease:potential biomarker for nigrostriatal failure[J].Arch Neurol,2008,65(6):698-699.

    [18] Schwarzschild M A,Schwid S R,Marek K,et al.Serum urate as a predictor of clinical and radiographic progression in Parkinson’s disease[J].Arch Neurol,2008,65(6):716-723.

    [19] Sun C C,Luo F F,Wei L,et al.Association of serum uric acid levels with the progression of Parkinson’s disease in Chinese patients[J].Chin Med J,2012,125(4):583-587.

    [20] Bartels A L,de Jong B M,Giladi N,et al.Striatal dopa and glucose metabolism in PD patients with freezing of gait[J].Mov Disord,2006,21(9):1326-1332.

    [21] Alvarez-Lario B,Macarron-Vicente J.Is there anything good in uric acid[J].QJM,2011,104(12):1015-1024.

    (收稿日期:2016-03-16) (本文编辑:程旭然), http://www.100md.com(武兵 庞家秉)
上一页1 2 3 4